# Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI

> **NCT01349257** · PHASE2 · COMPLETED · sponsor: **Chiesi Farmaceutici S.p.A.** · enrollment: 24 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** BDP/Formoterol

## Key facts

- **NCT ID:** NCT01349257
- **Lead sponsor:** Chiesi Farmaceutici S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-06
- **Final completion:** 2011-06
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2020-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01349257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01349257, "Pharmacokinetic Clinical Study of CHF1535 NEXT DPI® Versus CHF1535 pMDI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01349257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*